These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 760751)

  • 1. Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.
    Davies GJ; Marrott PK; Muir JR
    Br J Clin Pharmacol; 1979 Feb; 7(2):183-7. PubMed ID: 760751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
    Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
    N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of intravenous disopyramide in heart failure.
    Jensen G; Sigurd B; Uhrenholt A
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):167-73. PubMed ID: 1233215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous disopyramide in acute myocardial infarction: a haemodynamic and pharmacokinetic study.
    Cameron J; Stafford W; Pritchard D; Norris R; Ravenscroft P
    J Cardiovasc Pharmacol; 1984; 6(1):126-31. PubMed ID: 6199595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of intravenous disopyramide on the hemodynamics of patients hospitalized in intensive care units].
    Boland J; Lisin N; Marcelle R; Carlier J
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):145-51. PubMed ID: 1015909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1976; 199(1-2):41-51. PubMed ID: 1251772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
    Beltrame J; Aylward PE; McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1984; 6(3):483-90. PubMed ID: 6202976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of disopyramide in patients after open-heart surgery.
    Naqvi N; Thompson DS; Morgan WE; Williams BT; Coltart DJ
    Br Heart J; 1979 Nov; 42(5):587-94. PubMed ID: 316334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of glucagon.
    Murtagh JG; Binnion PF; Lal S; Hutchison KJ; Fletcher E
    Br Heart J; 1970 May; 32(3):307-15. PubMed ID: 5420074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction.
    Nelson GI; Ahuja RC; Silke B; Okoli RC; Hussain M; Taylor SH
    Eur Heart J; 1983 Oct; 4(10):706-11. PubMed ID: 6653580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamics of intravenous disopyramide.
    Sutton R
    J Int Med Res; 1976; 4(1 Suppl):46-8. PubMed ID: 1026528
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulatory effects of intravenous disopyramide in heart failure.
    Jensen G; Uhrenholt A
    J Int Med Res; 1976; 4(1 Suppl):42-5. PubMed ID: 1026527
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine.
    Kötter V; Linderer T; Schröder R
    Am J Cardiol; 1980 Sep; 46(3):469-75. PubMed ID: 7415992
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.
    Silke B; Frais MA; Verma SP; Reynolds GW; Hafizullah M; Kalra PA; Jackson NC; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):707-14. PubMed ID: 3105568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of nicardipine in acute myocardial infarction.
    Silke B; Verma SP; Hafizullah M; Reynolds G; Frais MA; Jackson NC; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():29-34. PubMed ID: 6527977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural evolution of left ventricular haemodynamics following uncomplicated acute myocardial infarction.
    Murray DP; Corbeij HM; Dunselman PH; Held PH; Hjalmarson A; Swedberg K
    Int J Cardiol; 1986 May; 11(2):175-86. PubMed ID: 3710624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanographic assessment of disopyramide in postinfarction patients.
    Sakadamis GC; Papadopoulos CL; Kanonidis IE; Papayiannis J; Giannakoulis IL; Gitsios C; Kokkas V
    Acta Cardiol; 1991; 46(5):567-75. PubMed ID: 1789051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction.
    Hillis WS; Tweddel A; Lorimer AR; Lawrie TD
    J Int Med Res; 1976; 4(1 Suppl):74-7. PubMed ID: 1026533
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.